ZHUHAI TRINOMAB BIOTECHNOLOGY CO LTD has a total of 12 patent applications. It increased the IP activity by 800.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CHOE MUHYEON, MODPRO AB and BIOVATION LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Therapeutic chemical compounds | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Yuan Xiaohui | 11 |
#2 | Liao Huaxin | 11 |
#3 | Wang Yueming | 11 |
#4 | Zheng Weihong | 7 |
#5 | Li Chengming | 1 |
#6 | Xiaohui Yuan | 1 |
#7 | Jia Zhenxing | 1 |
#8 | Weihong Zheng | 1 |
#9 | Wang Xiaoli | 1 |
#10 | Yueming Wang | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020098701A1 | Antibody against staphylococcus aureus α-hemolysin and uses thereof | |
WO2020124846A1 | Neutralizing antibody against respiratory syncytial virus and use thereof | |
EP3733699A1 | Completely humanized monoclonal neutralizing antibody for tetanus toxin and application thereof | |
WO2019210552A1 | Neutralizing antibody against tetanus toxin and use thereof | |
WO2019128121A1 | Anti-tetanus toxin neutralizing antibody, preparation method therefor, and uses thereof | |
WO2019128119A1 | Fully human monoclonal antibody for neutralizing tetanus toxin, and uses thereof | |
CN108218984A | A kind of full people source neutralizing antibody of anti-tetanus toxin |